香摄入量对健康志愿者的血液凝固测试的急性影响:一项随机试验
Reona Kimura1, Jonathon A Schwartz1, Jamie L Romeiser1
1Department of Anesthesiology, Stony Brook University, Stony Brook, NY, United States.
The journal of applied laboratory medicine
|February 1, 2024
概括
摄入香茶会延长前热血素时间 (PT),但临床意义尚不清楚. 香囊在健康志愿者中显示了一种非显著的PT延长趋势.
科学领域:
- 药理学 药理学是指药理学的学科.
- 草药是一种草药.
- 凝血科学 凝血科学
背景情况:
- 外科手术期间服用香可能会带来好处.
- 目前的做法建议不要进行外科手术期间的香,因为有出血风险.
- 这项研究研究了香对凝血的急性作用.
研究的目的:
- 为了评估香是否急剧延长凝血,在摄入后4小时内进行测试.
- 为了评估香茶和提取剂囊对前列血时间 (PT) 的影响.
主要方法:
- 八名健康的志愿者参加了一项交叉研究.
- 参与者接受了香茶或提取物囊.
- 摄入前和摄入后2小时和4小时分析了血液样本.
主要成果:
- 香茶显著增加了0.7秒 (P = 0.0078) 的最大前热血素时间 (PT).
- 香提取物囊显示,最大PT增加0.3秒 (P = 0.06),但不显著.
- 两种干预都没有达到临床意义的10%值;没有任何二次凝血参数发生显著变化.
结论:
- 在健康个体中,摄入香茶会延长PT.
- 这种PT延长的临床意义需要进一步调查.
- 香与出血风险有关的术后使用仍然不确定.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Disorders of Hemostasis
915
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
915
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
62
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
62
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K


